# Haleon takes hit from ‘weak cold and flu season’ but Sensodyne shines.

*biotech · news · 2026-04-29 · City A.M.*

## Key points

- Haleon's first-quarter sales volumes fell 0.2% due to a double-digit decline in cold and flu products.
- Sensodyne toothpaste sales grew 10%, now making India its second-largest market after the US.
- North America returned to growth for Haleon, achieving a 1% sales increase this quarter.
- Hedge fund Marshall Wace disclosed its first public short position in Haleon in May 2024.

**Companies:** Haleon
**Countries:** United Kingdom, United States, India

[Read the full story on City A.M.](https://www.cityam.com/haleon-takes-a-hit-from-weak-cold-and-flu-season-but-sensodyne-shines/)

---

Canonical: https://newsio.io/n/ab84f340-ea6f-48c9-a1e3-808271463e86/haleon-takes-hit-from-weak-cold-and-flu-season-but-sensodyne-shines-city-analyst
Summarized by Newsio from City A.M.. https://newsio.io/how-it-works